Ares Management Raises Over $2.3 Billion of Equity Commitments to Support the Long-Term Growth of Aspida

Ares Management Raises Over $2.3 Billion of Equity Commitments to Support the Long-Term Growth of Aspida

Aspida Is Well-Positioned to Meet the Growing Demand for Retirement Income and Solutions With Over $1.5 Billion of Dry Powder That Could Support Over $15 Billion of New Business

NEW YORK–(BUSINESS WIRE)–
Ares Management Corporation (“Ares”) (NYSE: ARES), a leading global alternative investment manager, announced today that it has raised over $2.3 billion of equity commitments from third parties, Ares and affiliates of Ares to support the long-term growth of Aspida Holdings Ltd. (“Aspida”). Aspida is a life insurance and annuity company based in Durham, N.C. and supported by the Ares Insurance Solutions (“AIS”) business as its dedicated investment management, capital solutions and corporate development partner. In addition, Aspida recently closed an oversubscribed offering of $700 million in credit facilities bringing total capital raised to more than $3 billion.

After launching four years ago, Aspida has organically grown its platform to over $19 billion in total assets, as of September 30, 2024, by leveraging its scalable, user-friendly technology platform designed to deliver high quality customer service to its individual annuity and reinsurance clients. Moreover, Aspida maintains an open architecture sub-advisor selection, which underscores its focus on seeking to maximize returns for clients. As part of that structure, the AIS team manages Aspida’s assets by leveraging significant insurance investment experience, differentiated asset origination and asset-liability and capital management solutions. With the strength of the Ares platform, the AIS team has helped build Aspida a diversified portfolio of high-quality investments that is over 90% investment grade and well-matched to its liabilities.

“This is a remarkable milestone for Aspida, and the Ares team is proud to provide continued support through our capital investment and the AIS team’s services,” said David Reilly and Ryan Myrick, Partners and Co-Heads of AIS. “Propelled by secular tailwinds, including increased life expectancy, rising health care costs and elevated expenses, retirement planners have turned to annuities to offer enhanced after-tax returns. By pairing Aspida’s spread-based business model and digital platform with AIS’s leading asset origination and investment capabilities, we believe Aspida is well-positioned to capitalize on these trends and drive continued growth and value creation for its clients and investors.”

“We are excited to announce this significant achievement for Aspida, which reflects the growing demand for our versatile platform offerings and the strength of our relationship with Ares,” said Lou Hensley, Chief Executive Officer and President of Aspida. “In just four years, we are delivering on our mission to support clients’ financial security by leveraging cutting-edge technology designed to provide superior speed, service and scalability. Combined with access to Ares’ leading global investment platform, Aspida has been able to capitalize on the increasing demand for retirement solutions. On behalf of the entire Aspida team, I want to extend my gratitude to Ares and all our investors for their continued trust and confidence in Aspida’s vision and future.”

About Ares Management Corporation

Ares Management Corporation (NYSE: ARES) is a leading global alternative investment manager offering clients complementary primary and secondary investment solutions across the credit, real estate, private equity and infrastructure asset classes. We seek to provide flexible capital to support businesses and create value for our stakeholders and within our communities. By collaborating across our investment groups, we aim to generate consistent and attractive investment returns throughout market cycles. As of September 30, 2024, Ares Management Corporation’s global platform had approximately $464 billion of assets under management, with more than 3,100 employees operating across North America, Europe, Asia Pacific and the Middle East. For more information, please visit www.aresmgmt.com.

About Aspida

Aspida Holdings Ltd., through its subsidiaries (collectively “Aspida”), is focused on providing retirement and reinsurance solutions, with total assets of over $19 billion as of September 30, 2024. Aspida’s U.S. platform – Aspida Life Insurance Company – is based in Durham, N.C., and focuses on leveraging technology and agility to help clients achieve – and protect – their dreams. Aspida Re, with offices in Hamilton, Bermuda and the Cayman Islands, is focused on providing efficient and secure reinsurance solutions to life and annuity clients globally. Aspida seeks to be a trusted partner in its clients’ financial security while driving its growth by doing good for the communities it serves. A subsidiary of Ares Management Corporation (NYSE: ARES) acts as the dedicated investment manager, capital solutions and corporate development partner to Aspida. For more information, please visit: www.aspida.com or follow them on LinkedIn.

Ares Media:

Jacob Silber, +1-212-301-0376

[email protected]

Aspida Media:

Blaire Swayze

[email protected]

KEYWORDS: North Carolina New York United States North America

INDUSTRY KEYWORDS: Public Relations/Investor Relations Business Communications Professional Services Insurance

MEDIA:

Logo
Logo

Apogee Enterprises Increases Quarterly Dividend

Apogee Enterprises Increases Quarterly Dividend

Apogee’s Twelfth Consecutive Year with a Dividend Increase

MINNEAPOLIS–(BUSINESS WIRE)–Apogee Enterprises, Inc. (Nasdaq: APOG) announced today that its Board of Directors has declared a quarterly cash dividend of $0.26 per share, a 4% increase from its previous quarterly dividend rate of $0.25 per share. The dividend will be payable on February 12, 2025, to shareholders of record at the close of business on January 28, 2025. This marks Apogee’s twelfth consecutive year with a dividend increase, during which time the quarterly dividend has grown by 189%, from $0.09 per share to $0.26 per share.

About Apogee Enterprises, Inc.

Apogee Enterprises, Inc. (Nasdaq: APOG) is a leading provider of architectural building products and services, as well as high-performance coated materials used in a variety of applications. Headquartered in Minneapolis, MN, our portfolio of industry-leading products and services includes architectural glass, windows, curtainwall, storefront and entrance systems, integrated project management and installation services, and high-performance coatings that provide protection, innovative design, and enhanced performance. For more information, visit www.apog.com.

Jeff Huebschen

Vice President, Investor Relations & Communications

952.487.7538

[email protected]

KEYWORDS: Minnesota United States North America

INDUSTRY KEYWORDS: Architecture Other Construction & Property Manufacturing Commercial Building & Real Estate Construction & Property Building Systems Other Manufacturing

MEDIA:

Logo
Logo

Trane Technologies Schedules Fourth Quarter 2024 Earnings Conference Call

Trane Technologies Schedules Fourth Quarter 2024 Earnings Conference Call

SWORDS, Ireland–(BUSINESS WIRE)–
Trane Technologies plc (NYSE:TT), a global climate innovator, will host a conference call to discuss its fourth quarter 2024 financial results on Thursday, January 30, 2025, at 10 a.m. ET. The company will issue its fourth quarter earnings release and earnings presentation in advance of the call; both will be available on the Trane Technologies website.

A real-time, listen-only webcast of the conference call will be broadcast live over the internet. Individuals wishing to listen can access the call through the company’s website at www.tranetechnologies.com under the investor relations section.

For those unable to listen to the live event, a replay will be available on the company’s website at approximately 1 p.m. ET, January 30, 2025.

About Trane Technologies

Trane Technologies is a global climate innovator. Through our strategic brands Trane® and Thermo King®, and our portfolio of environmentally responsible products and services, we bring efficient and sustainable climate solutions to buildings, homes, and transportation. Learn more at tranetechnologies.com.

Media: 

Travis Bullard 

+1 919-802-2593 

[email protected]

Investors:

Zachary Nagle

+1 704-990-3913

[email protected]

KEYWORDS: Ireland Europe

INDUSTRY KEYWORDS: HVAC Environment Manufacturing Sustainability Commercial Building & Real Estate Construction & Property Building Systems

MEDIA:

Logo
Logo

Henry Schein Opens Customer Emergency Support Hotline in Response to California Fires

Henry Schein Opens Customer Emergency Support Hotline in Response to California Fires

Dental and Medical Professionals Who May Experience Operational, Logistical, or Financial Issues Are Encouraged to Call 800-999-9729

MELVILLE, N.Y.–(BUSINESS WIRE)–
Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers throughout California that the Henry Schein Customer Emergency Support Hotline is open for dental and medical professionals who may experience operational, logistical, or financial issues as a result of damage caused by the ongoing fires.

The toll-free number for all Henry Schein customers is 800-999-9729. The hotline is open 24/7, with real-time assistance available from Team Schein Members from 8 a.m. to 8 p.m. Eastern Time.

“We are deeply saddened by the immense loss caused by the fires in California, and our hearts go out to all the affected communities,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. “Our hotline remains open, and we are here to assist customers, provide guidance, and stand by dental and medical professionals to navigate this difficult time together.”

The Henry Schein Customer Emergency Support Hotline remains open throughout the year to help practitioners during preparation and recovery from emergencies. The Emergency Preparedness Guide for Henry Schein Customers provides steps to help practices minimize the impact of a natural disaster and swiftly return to operations. To help meet the challenges of rebuilding a practice in the wake of a natural disaster, practitioners can download the Emergency Recovery Guide for Office-Based Health Care Practitioners. For more information about Henry Schein’s emergency preparedness and relief resources for practices, please click here.

About Henry Schein Cares

Founded in 1932 by Henry and Esther Schein, our Company has a rich history rooted in corporate citizenship. Their values inspired our commitment to innovation, leadership, and strong partnerships and serve as a driving force behind our ability to adapt to changing industry needs. Today, Henry Schein Cares, our global corporate citizenship program, aims to drive change through our five pillars: catalyzing health care access; advancing policies, solutions, and innovation; relationship building for change; empowering Team Schein; and sustaining the planet. Our purpose is to drive this positive change through the engagement of our constituents to help make the world healthier. By adhering to these pillars, we are committed to “doing well, by doing good” and recognize the importance of being accountable to the five constituents that make up the Company’s Mosaic of Success — customers, suppliers, Team Schein Members, shareholders, and society at large.

To learn more about how we are making a difference, please visit: www.henryschein.com/corporatecitizenship.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 26,000 Team Schein Members worldwide, the Company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company’s sales reached $12.3 billion in 2023, and have grown at a compound annual rate of approximately 11.5 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, LinkedIn.com/Company/HenrySchein, and @HenrySchein on X.

Ann Marie Gothard

Vice President, Global Corporate Media Relations

[email protected]

+1 (631) 390-8169

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Medical Devices Medical Supplies Dental Philanthropy Other Health Health Fund Raising General Health Other Philanthropy

MEDIA:

Logo
Logo

Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing

Sharing Insights at the ‘Italy on the Move’ Event and Engaging Investors at Biotech Showcase During JPM Healthcare Week in San Francisco

MILAN and NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) — Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, is pleased to announce that it has strengthened its partnership with AGC Biologics, a global contract development and manufacturing organization (CDMO), by amending their Development and Master Services Agreement. This amendment introduces an exclusive GMP suite at the AGC Biologics Cell and Gene Center of Excellence in Milan, dedicated to the manufacturing of Genenta’s cell therapy product, ensuring compliance with cGMP standards. This strategic move enhances Genenta’s production capabilities, potentially improving efficiency and reliability in its manufacturing processes.

The newly approved methastatic Renal Cell Cancer (mRCC) Phase 1/2a trial began in Q4 2024, and Genenta expects to treat six patients by the end of the first half of 2025, while continuing progress with the Glioblastoma Multimforme (GBM) study. In total, Genenta projects manufacturing 27 autologous drug products in 2025.

Our strengthened partnership with AGC Biologics represents our unwavering commitment to patients participating in our GBM and mRCC trials,” said Pierluigi Paracchi, CEO and Co-founder of Genenta. “This enhanced capacity ensures that we can treat a larger number of patients and further validate our therapeutic approach, bringing us closer to our vision of transforming cancer treatment through cell-based therapies.

Prof. Luigi Naldini, Co-founder of Genenta, noted: “Our recent preclinical and clinical studies underscore Temferon’s unique potential to reprogram the tumor microenvironment, inhibiting myeloid cell-induced immune suppression and fostering T-cell responses. This approach not only enhances the potential efficacy of Temferon as a monotherapy but also suggests promising synergies when combined with various immunotherapeutic strategies, including immune checkpoint inhibitors and CAR-T cell therapies. These findings provide a strong foundation for advancing therapeutic strategies targeting solid tumors and bring us closer to open up new cancer treatments.

Upcoming Engagements during JPM Healthcare Week: Genenta will participate in Biotech Showcase 2025, taking place January 13–15, 2025, in San Francisco to present its innovative technology for treating solid tumors through genetically modified cell therapy. Pierluigi Paracchi will also speak at “Italy on the Move”, a flagship biotech event organized by the Italian Ministry of Foreign Affairs and International Cooperation. The event, aimed at promoting Italy’s life sciences sector and fostering international investments, will be held on January 15, 2025, at INNOVIT – Italian Innovation and Culture Hub in San Francisco. Notable speakers include Karthic Jayaraman, Partner and Co-Head of Global Healthcare at TPG Capital, and Frederick Beddingfield, CEO of Rubedo Life Sciences. The event will be moderated by Audrey Greenberg, Co-Founder and Executive Managing Director of the Center for Breakthrough Medicines.

About Genenta

Genenta (Nasdaq: GNTA) is a clinical stage immuno-oncology company developing a proprietary hematopoietic stem cells therapy for the treatment of a variety of solid tumor cancers. Genenta’s first in class product candidate is Temferon™, which is designed to allow the expression of immune-therapeutic payloads within the tumor microenvironment by bone marrow derived myeloid cells and enable a durable and targeted response. Genenta has completed a Phase 1 trial for newly diagnosed Glioblastoma Multiforme patients with an unmethylated MGMT gene promoter, which suggests the potential reprogramming of the tumor microenvironment and inhibiting of myeloid induced tolerance, while allowing the induction of T cell responses, potentially breaking immune tolerance. Genenta has initiated in Q4 2024 a Phase 1/2a metastatic Renal Cell Carcinoma study that will also include combination with immune checkpoint inhibitors. Our treatments are designed as one-time monotherapies, but with the additional potential, when used in combination, to significantly enhance the efficacy of other approved therapeutics.

Forward-Looking Statements

Statements in this press release contain “forward-looking statements,” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “suggest,” “target,” “aim,” “should,” “will,” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Genenta’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict, including risks related to the completion and timing of its ongoing clinical trial for newly diagnosed GBM patients with uMGMT-GBM, its expected clinical trial for metastatic RCC or any related studies, as well as Genenta’s ability to fund its research and development plans. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section titled “Risk Factors” in Genenta’s Annual Report on Form 20-F for the year ended December 31, 2023 filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of the date of this announcement, and Genenta undertakes no duty to update such information except as required under applicable law.

This press release discusses product candidates that are under preclinical or clinical evaluation and that have not yet been approved for marketing by the U.S. Food and Drug Administration or any other regulatory authority. Until finalized in a clinical study report, clinical trial data presented herein remain subject to adjustment as a result of clinical site audits and other review processes. No representation is made as to the safety or effectiveness of these product candidates or the use for which such product candidates are being studied. Temferon™ is an investigational product candidate for which the effectiveness and safety have not been established. In addition, Temferon™ is not approved for use in any jurisdiction.

Genenta Media
Tiziana Pollio, Mobile: +39 348 23 15 143
Email: [email protected]



BJ’s Wholesale Club Kicks Off 2025 with Grand Opening of Maryville, TN Location

BJ’s Wholesale Club Kicks Off 2025 with Grand Opening of Maryville, TN Location

BJ’s Gas Opens January 9 with Club to Follow on January 17

MARLBOROUGH, Mass. & MARYVILLE, Tenn.–(BUSINESS WIRE)–BJ’s Wholesale Club (NYSE: BJ) announced today that its club in Maryville, Tennessee, will open on January 17, 2025.

The club, located at 101 Foothills Mall Drive, is BJ’s fourth club in Tennessee. The on-site BJ’s Gas location opens January 9 with everyday low fuel prices and potential extra savings through BJ’s Fuel Saver Program.

BJ’s offers unmatched value on everyday essentials in a convenient one-stop shop. Members can save on fresh foods, produce, full-service deli items, fresh bakery goods, household essentials, home décor, pet supplies, toys, tech and more. BJ’s members love the true treasure-hunt shopping experience, finding new and exciting items with every visit.

“BJ’s Wholesale Club is dedicated to taking care of the families who depend on us,” said Lisa Kessler Gammon, Club Manager, Maryville BJ’s Wholesale Club. “We are excited to bring unbeatable value and savings of up to 25% off grocery store prices every day to the families in and around Maryville.”

BJ’s has a longstanding commitment to nourishing its communities. For over 15 years, it has worked with Feeding America and its network of food banks, providing more than 125 million meals for those in need. In the Maryville community, BJ’s is partnering with Second Harvest Food Bank of East Tennessee by donating unsold produce, meat, dairy and more every week.

Additionally, BJ’s Charitable Foundation has awarded Second Harvest Food Bank of East Tennessee a $50,000 grant in support of the Food for Kids program, providing nutritious, easily prepared food for children who are likely to miss meals on a regular basis. The funding will directly support 500 Maryville area students.

“We’re thrilled to welcome BJ’s Wholesale Club as a partner in our community,” said Elaine Streno, Executive Director of Second Harvest Food Bank of East Tennessee. “BJ’s support has already had a significant impact on those who rely on us. We look forward to fostering our partnership as we work together to provide meals and advance hunger solutions in our communities.”

BJ’s members can choose from several time-saving options whether shopping online or in-club. Curbside pick-up, in-club pick-up, same-day delivery* and standard delivery are available on BJs.com, while members shopping in-club can use ExpressPay** through the BJ’s mobile app to scan products as they shop and skip the checkout line.

Additional member perks include:

  • Unbeatable grocery store prices: Members can save up to 25% off grocery store prices every day

  • A risk-free membership: Shoppers can try BJ’s risk-free with the company’s 100% money-back guaranteed membership

  • BJ’s coupons + manufacturers’ coupons: Members can combine BJ’s coupons with many manufacturers’ coupons for maximum savings

  • BJ’s Gas: Members can fill up at any BJ’s Gas® locations at low prices. Plus, members can save even more through BJ’s Fuel Saver Program

Local shoppers can join the new club now with limited-time exclusive offers***. New members can sign up for The Club Card Membership at $55 for 1-year membership with BJ’s Easy Renewal® and get a $40 welcome reward> or The Club+ Card Membership at $110 for 1-year membership with BJ’s Easy Renewal® and get an $80 welcome reward>. The Club+ Card Membershipholders receive 5¢ off/gal. at BJ’s Gas and earn 2% back†† in rewards‡‡ on most BJ’s purchases.

All BJ’s memberships are subject to BJ’s current membership terms, ask in-club or go to BJs.com/terms.

About BJ’s Wholesale Club Holdings, Inc.

BJ’s Wholesale Club Holdings, Inc. (NYSE: BJ) is a leading operator of membership warehouse clubs focused on delivering significant value to its members and serving a shared purpose: “We take care of the families who depend on us.” The company provides a wide assortment of fresh foods, produce, a full-service deli, fresh bakery, household essentials, various exclusive offerings, gas and more to deliver unbeatable value to smart-saving families. Headquartered in Marlborough, Massachusetts, the company pioneered the warehouse club model in New England in 1984 and currently operates 248 clubs and 183 BJ’s Gas® locations in 20 states. For more information, please visit us at www.BJs.com or on Facebook, or Instagram.

About Second Harvest Food Bank of East Tennessee

Second Harvest Food Bank of East Tennessee, a member of Feeding America, has worked to compassionately feed East Tennesseans experiencing hunger since 1982. Last year, Second Harvest distributed more than 26.3 million pounds of food across an 18-county service area through eight hunger-relief programs and 670+ community partners.

*BJ’s Same-Day Delivery is not available in all ZIP codes. Log in to your account to confirm availability.

**30 items per transaction limit. Only available for purchases up to $750. Paper coupons not applicable. Cannot be used to purchase gift cards, alcohol, cigarettes, propane, appliances, fireworks, security-protected items or tires.

***Offer is valid at the Maryville, TN, membership center and online at www.bjs.com/maryville only, may not be combined with other offers, not redeemable for cash, non-transferable and only good for new members. Plus, sales tax where applicable. Offer is contingent upon your enrolling in BJ’s Easy Renewal®, and you authorize BJ’s to charge the debit/credit card first used at BJ’s after accepting this offer, an annual recurring charge in the amount of the then-current membership fee for all active memberships on your account, plus tax where applicable, on the first day of the month your membership expires. Expires: 1/16/25.

A $40 welcome reward (for new The Club Card members) or an $80 welcome reward (for new The Club+ Card members) will be added to the primary membership account 24 hours after enrollment to be used within 60 days. Redeemable in-club, in the BJ’s mobile app and on BJs.com. If not redeemed, welcome reward will no longer be available. This special rewards offer is separate from the BJ’s One® Mastercard® program and does not alter its terms.

††The Club+ Card members earn 2% back in rewards on eligible purchases of goods and services in-club at BJ’s front-end registers, on BJs.com, or in the BJ’s app (minus any redeemed rewards, returns, refunds, or credit adjustments) when they scan their membership card for these purchases, unless the primary member or the member making the purchase is a cardholder in the BJ’s One® Mastercard® program, in which case the member will only earn rewards in accordance with the BJ’s One® Mastercard® program rewards terms (see BJs.com/bjsoneterms). Rewards earned may not exceed $500 in any 12-month period. Eligible purchases exclude eye exams, shipping, sales tax, bottle deposits, alcoholic beverages, cigarettes and tobacco-related products, lottery tickets, gift cards, propane, BJ’s Gas®, online optical purchases, membership fees and add-ons, warranties and protection plans, BJ’s services provided by third parties (e.g., BJ’s Travel®), and BJ’s B2B and BJ’s Global Sales transactions. See BJs.com/terms for information on excluded services. Eye exams and online optical purchases are not eligible for reward redemption.

The Club+ Card members receive an instant discount of 5¢ off each gallon of fuel purchased at BJ’s Gas® when they scan their membership card for these purchases, unless the primary member or the member making the purchase is a cardholder in the BJ’s One® Mastercard® program, in which case the member will only receive an instant discount at BJ’s Gas® in accordance with the BJ’s One® Mastercard® program rewards terms (see BJs.com/bjsoneterms). BJ’s Gas® purchases are not eligible purchases and do not earn rewards. For MD and NJ transactions, discount will be applied after sale, before payment. Subject to applicable state law restrictions.

‡‡Rewards are yours for the life of your The Club+ Card Membership – they will not expire while your membership remains active and in good standing. Rewards earned may not exceed $500 in any 12-month period. Must have a minimum balance of $10 in rewards to redeem. Minimum eligible purchase amount is $10 at BJ’s checkout. The rewards program is provided by BJ’s Wholesale Club, Inc. and its terms may change at any time. For full rewards terms and conditions, please see BJs.com/terms.

Media:

Kirk Saville

Head of Corporate Communications

BJ’s Wholesale Club

[email protected]

774-512-5597

Briana Keene

Sr. Manager, External Communications

BJ’s Wholesale Club

[email protected]

774-512-6802

KEYWORDS: Tennessee Massachusetts United States North America

INDUSTRY KEYWORDS: Online Retail Supermarket Discount/Variety Philanthropy Department Stores Food/Beverage Fashion Convenience Store Retail Foundation Home Goods

MEDIA:

Logo
Logo

WeRide Expands European Presence with Autonomous Robobus Shuttle Deployment at Zurich Airport

ZURICH, Jan. 09, 2025 (GLOBE NEWSWIRE) — WeRide Inc. (NASDAQ: WRD), a global leader in autonomous driving technology, today announced deployment of its Robobus autonomous shuttle service at Zurich Airport in partnership with Flughafen Zürich AG and Swiss Transit Lab (STL), marking a significant milestone in bringing autonomous mobility solutions to a major European aviation hub, and building on WeRide’s successful European operations, including its recent autonomous shuttle service at Roland-Garros during the 2024 French Open.

The WeRide Robobus, which accommodates nine passengers, will be the first commercial autonomous bus shuttle project at a European airport. It will serve airport employees along a dedicated route connecting the employee entrance at gate 101 to the maintenance area at gate 130. Service will begin in the first quarter of 2025.

Flughafen Zürich AG is working with airports in Brussels and Amsterdam that are also testing technologies for autonomous vehicles. Before the start of test Robobus operations, WeRide’s autonomous taxi, Robotaxi, completed route mapping at Zurich Airport, demonstrating that WeRide’s Robotaxi will have more applications in Switzerland.

At the foot of the Alps, Zurich Airport presents severe challenges to autonomous driving technology due to complex operational environment and climatic conditions. WeRide successfully overcame these challenges with its strong technical capabilities and rich implementation experience, providing a mature and reliable solution.

The Zurich Airport service follows the successful deployment in Paris, where Robobus provided efficient shuttle services on a five-kilometer route during the French Open, as part of an ongoing collaboration with Renault Group to promote low-carbon public transportation solutions.

The Robobus deployment leverages WeRide’s advanced autonomous driving technology, which has undergone extensive testing and validation across more than 30 cities in seven countries. The initial phase at Zurich Airport includes a safety driver on board, with plans to transition to remote monitoring operations.

“WeRide possesses a fully developed and thoroughly tested technology, meets all of the legal and safety requirements in place at Zurich Airport and guarantees that it will meet the data protection requirements set out,” Flughafen Zürich AG said in a statement.

The Company will work with Swiss Transit Lab to ensure smooth operation of the service.

Contact

Edmond Lococo

ICR, LLC


[email protected]

+1 (332) 242-4398



O2 Czech Republic Launches Allot Solution to Offer Consumer Cybersecurity Services

Hod Hasharon, Israel, Jan. 09, 2025 (GLOBE NEWSWIRE) — Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT), a leading global provider of innovative network intelligence and converged network-native security solutions for communication service providers and enterprises, today announced that O2 Czech Republic, a subsidiary of the PPF Group, has launched Allot DNS Secure, enabling them to continue offering and enhance cybersecurity protection services to both their mobile and fixed broadband consumer customers.

This service launch is the result of an agreement between Allot and O2 Czech Republic signed earlier this year, and of an umbrella agreement signed with O2 Czech Republic parent company PPF Group to supply cybersecurity solutions to the group’s telecom provider subsidiaries. Allot will benefit from a recurring monthly fee for cybersecurity protection services provided to O2 Czech Republic

“Our decision to partner with Allot for consumer security services was driven by the positive feedback we received from our colleagues at PPF Group, as well as by the impressive value offered by Allot,” commented Jan Hruška, O2 Czech Republic Chief Technology Officer. “We are confident that the Allot solution will significantly enhance O2 Czech Republic’s ability to safeguard our consumer customers from cyber threats.”

“With O2 Czech Republic becoming the fifth operator within the PPF Group to embrace our security services, the Allot team is thrilled to see the growing adoption of DNS Secure. Our solution provides scalable, telco-grade, network-native services tailored for the mass consumer market, making it an ideal choice for operators seeking a reliable and straightforward approach to customer security,” said Amir Oren, Vice President of Sales, EMEA at Allot.

The Allot DNS Secure solution provides protection against a range of cyber threats including, viruses, ransomware, trojans and phishing attacks. The agreement also includes parental controls to give parents peace of mind when deciding which content is inappropriate for their children’s consumption.

###

Additional Resources:

Allot Blog: https://www.allot.com/blog
Telco CyberTalk Podcast: https://www.allot.com/resources/podcasts
Follow us on Twitter: @allot_ltd
Follow us on LinkedIn: https://www.linkedin.com/company/allot-communications

About Allot

Allot Ltd. (NASDAQ: ALLT, TASE: ALLT) is a provider of leading innovative network intelligence and converged security solutions for service providers and enterprises worldwide, enhancing value to their customers. Our solutions are deployed globally for network and application analytics, traffic control and shaping, network-native security services, and more. Allot’s multi-service platforms are deployed by over 500 mobile, fixed and cloud service providers and over 1000 enterprises. Our industry-leading network-native security-as-a-service solution is already used by many millions of subscribers globally.

Allot. See. Control. Secure.

Forward-Looking Statement

This release contains forward-looking statements, which express the current beliefs and expectations of Company management. Such statements involve a number of known and unknown risks and uncertainties that could cause our future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied in such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our accounts receivables, including our ability to collect outstanding accounts and assess their collectability on a quarterly basis; our ability to meet expectations with respect to our financial guidance and outlook; our ability to compete successfully with other companies offering competing technologies; the loss of one or more significant customers; consolidation of, and strategic alliances by, our competitors; government regulation; the timing of completion of key project milestones which impact the timing of our revenue recognition; lower demand for key value-added services; our ability to keep pace with advances in technology and to add new features and value-added services; managing lengthy sales cycles; operational risks associated with large projects; our dependence on fourth party channel partners for a material portion of our revenues; and other factors discussed under the heading “Risk Factors” in the Company’s annual report on Form 20-F filed with the Securities and Exchange Commission. Forward-looking statements in this release are made pursuant to the safe harbor provisions contained in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made only as of the date hereof, and the company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.



Seth Greenberg
Allot
+972.54 922 2294
[email protected]

Ehud Helft
Allot Investor Relations
+1-212-378-8040
[email protected]

KKR Further Extends Second Tender Offer for FUJI SOFT

KKR Further Extends Second Tender Offer for FUJI SOFT

KKR Continues to Be Committed to FUJI SOFT’s Privatization; Will Not Withdraw its Second Tender Offer

TOKYO–(BUSINESS WIRE)–
KKR, a leading global investment firm, announced today that in connection with the Second Tender Offer in its two-stage tender offer scheme (the “Tender Offer”) for the common shares and share options of FUJI SOFT INCORPORATED (“FUJI SOFT” or the “Company”; TSE stock code 9749) through FK Co., Ltd. (the “Offeror” or “FK Co.”), an entity owned by investment funds managed by KKR, the Offeror has submitted an amendment statement to the Tender Offer Registration Statement that was submitted on November 20, 2024 (including the matters amended in the amendment statement to the Tender Offer Registration Statement submitted on December 19, 2024) (the “Amendment Statement”).

Further Extension of Second Tender Offer

The Amendment Statement was submitted due to the Offeror’s decision to extend the end date of the tender offer period for the Second Tender Offer from January 9, 2025 to January 24, 2025. The tender offer price per common share will remain at 9,451 yen, and there is no change to the price that is being considered.

The extension of the tender offer period is intended to allow the Company’s shareholders and share option holders to make a considered decision, in light of the fact that as of January 9, 2025, the market price of the Company’s shares has stayed above the Second Tender Offer price while the market continues to digest the following announcements:

  • Bain Capital’s press releases dated December 11, 2024, December 18, 2024, and January 7, 2025;

  • FUJI SOFT’s press releases dated December 17, 2024, January 7, 2025, and January 8, 2025; and

  • The Offeror’s press release dated December 19, 2024 and January 6, 2025.

Doubts Regarding the Feasibility of Bain Capital’s Tender Offer

Bain Capital waived the support of the Board of Directors of the Company as a condition precedent to the commencement of its tender offer and set a maximum number of shares to be purchased at 31,444,443 shares (ownership ratio: 49.89%) in the amendment to the terms of its tender offer on December 18, 2024. As a result, Bain Capital’s tender offer is no longer intended to take the Company private and has changed into a “hostile partial tender offer with the aim of seizing control of the company.” In addition, Bain Capital made it a condition precedent of their tender offer that the Second Tender Offer by the Offeror be unsuccessful or withdrawn, and Bain Capital has expressed its intention to commence its tender offer from late January 2025 or after.

FK Co., however, has no intention to withdraw the Second Tender Offer. Even in the scenario that the Second Tender Offer is not successful, FK Co., as the largest shareholder whose support is required in any privatization through a minority squeeze-out, remains committed to privatizing FUJI SOFT, and will conduct a new tender offer at the same tender offer price as that of the Tender Offer.

Given that the conditions required to fulfil Bain Capital’s tender offer will not occur, and accordingly the very low likelihood of FUJI SOFT changing its “Oppose” opinion for Bain Capital, the Offeror believes there will not be a tender offer by Bain Capital that investors can tender into.

This belief is supported by the fact that while Bain Capital stated on November 1, 2024 that it would commence its tender offer immediately upon obtaining the approval of FUJI SOFT, which was its outstanding condition precedent, it has not launched any tender offer after waiving this requirement on December 18, 2024. The Offeror logically concludes that if Bain Capital, with no outstanding conditions precedent to fulfil, has not launched an unsolicited tender offer as it said it would, it is because Bain Capital either has no actual intention to launch an unsolicited tender offer or that it is unable to do so, for reasons such as completing the appointment of a tender offer agent due to Bain Capital’s breach of its confidentiality agreement with FUJI SOFT or securing the necessary financial commitments including for the minority squeeze-out. Bain Capital has also not provided a reasonable explanation for why it has not commenced its unsolicited tender offer.

Founding Family and Bain Capital Reached Out to KKR to Propose Collaboration

Bain Capital stated in its press release dated January 7, 2025 that “upon consultation and negotiation with the shareholders of the Company, including FK Co., Ltd. and other shareholders of the Company, the Tender Offeror [Bain Capital] plans to commence the Tender Offer in late January 2025 or early February 2025, as soon as the disclosure documents are prepared.”

On December 27, 2024, Nomura Securities, the financial advisor to FUJI SOFT’s Founding Family, reached out to KKR on behalf of the Founding Family to propose that the three parties, specifically the Founding Family, the Offeror, and Bain Capital, could work together to take FUJI SOFT private.

KKR Continues to be Committed to FUJI SOFT’s Privatization

KKR continues to have strong regard for FUJI SOFT’s growth potential and intends to leverage KKR’s global network and resources and work together with FUJI SOFT’s management and employees to provide better services and solutions for customers and achieve further business growth and value creation for FUJI SOFT as well as for its stakeholders including management, employees, and customers after the privatization.

KKR believes that it is desirable for all stakeholders to see FUJI SOFT be taken private as soon as possible and to work on measures to enhance corporate value.

For details on the Amendment Statement, please refer to the release issued by the Offeror today titled “(Amendment) Notice Regarding Amendment to “Notice Regarding the Commencement of Tender Offer for the Shares of FUJI SOFT INCORPORATED (Securities Code: 9749) by FK Co., Ltd.” Following Submission of Amendment Statement to the Tender Offer Registration Statement by FK Co., Ltd.” (the “Amendment Release”).

***

This press release should be read in conjunction with the Amendment Release.

The purpose of this press release is to publicly announce an extension to the tender offer period for the Second Tender Offer and it has not been prepared for the purpose of soliciting an offer to sell or purchase in the Tender Offer. When making an application to tender, please be sure to read the relevant Tender Offer Explanatory Statement for the Tender Offer and make your own decision as a shareholder or share option holder. This press release does not constitute, either in whole or in part, a solicitation of an offer to sell or purchase any securities, and the existence of this press release (or any part thereof) or its distribution shall not be construed as a basis for any agreement regarding the Tender Offer, nor shall it be relied upon in concluding an agreement regarding the Tender Offer.

The Tender Offer will be conducted in compliance with the procedures and information disclosure standards set forth in Japanese law, and those procedures and standards are not always the same as the procedures and information disclosure standards in the U.S. In particular, neither sections 13(e) or 14(d) of the U.S. Securities Exchange Act of 1934 (as amended; the same shall apply hereinafter) or the rules under these sections apply to the Tender Offer; and therefore the Tender Offer will not be conducted in accordance with those procedures and standards.

Unless otherwise specified, all procedures relating to the Tender Offer are to be conducted entirely in Japanese. All or a part of the documentation relating to the Tender Offer will be prepared in English; however, if there is any discrepancy between the English-language documents and the Japanese-language documents, the Japanese-language documents shall prevail.

This press release includes statements that fall under “forward-looking statements” as defined in section 27A of the U.S. Securities Act of 1933, as amended, and section 21E of the Securities Exchange Act of 1934. Due to known or unknown risks, uncertainties or other factors, actual results may differ materially from the predictions indicated by the statements that are implicitly or explicitly forward-looking statements. Neither the Offeror nor any of its affiliates guarantee that the predictions indicated by the statements that are implicitly or expressly forward-looking statements will materialize. The forward-looking statements in this press release were prepared based on information held by the Offeror as of today, and the Offeror and its affiliates shall not be obliged to amend or revise such statements to reflect future events or circumstances, except as required by laws and regulations.

The Offeror, its financial advisors and the Tender Offer agent (and their respective affiliates) may purchase the common shares and share options of FUJI SOFT, by means other than the Tender Offer, or conduct an act aimed at such purchases, for their own account or for their client’s accounts, in the scope of their ordinary business and to the extent permitted under financial instrument exchange-related laws and regulations, and any other applicable laws and regulations in Japan, in accordance with the requirements of Rule 14e-5(b) of the U.S. Securities Exchange Act of 1934. Such purchases may be conducted at the market price through market transactions or at a price determined by negotiations off-market. In the event that information regarding such purchases is disclosed in Japan, such information will also be disclosed on the English website of the person conducting such purchases (or by any other method of public disclosure).

About KKR

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.

For more information, please contact:

Media Contact

KKR Asia Pacific

Wei Jun Ong

+65 6922 5813

[email protected]

KEYWORDS: Japan Asia Pacific

INDUSTRY KEYWORDS: Asset Management Professional Services Finance

MEDIA:

Logo
Logo

Philips appoints Jie Xue as Chief Business Leader Precision Diagnosis, co-leader of the Diagnosis & Treatment segment, and Özlem Fidanci as Chief of International Region


January 9, 2025

Amsterdam, the Netherlands –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the appointment of Jie Xue as Chief Business Leader Precision Diagnosis, and Özlem Fidanci as Chief of International Region, both effective January 1, 2025. Ms. Xue and Ms. Fidanci have joined Philips’ Executive Committee and report directly to Roy Jakobs, CEO of Philips.

Ms. Xue joins Philips from GE Healthcare to lead the Precision Diagnosis business that was temporarily led by Bert van Meurs, who will continue to lead Philips’ Image Guided Therapy business. Ms. Xue and Mr. Van Meurs will be jointly responsible for the Diagnosis & Treatment segment.
 
Ms. Fidanci joins from Versuni and succeeds Edwin Paalvast, Chief of International Region, who has decided to retire as planned after five years at Philips, concluding an impressive career spanning more than 35 years.

Roy Jakobs, CEO Philips, said: “In Jie we have a strong proven global leader, with deep medtech expertise, and a focus on creating value through developing people and consistently delivering results. Özlem brings an extensive track record in delivering high growth in mature and emerging markets, working closely with customers and governments. She has strong experience in consumer and medtech domains and is known for building high-performing teams. Jie and Özlem strengthen our experienced and diverse leadership team and will support us in realizing our vision of better care for more people.” 

“I want to thank Edwin for his leadership and many achievements during his five years at Philips and wish him all the very best for his retirement. I also want to express my gratitude to Bert for leading Precision Diagnosis alongside his role as Chief Business Leader Image Guided Therapy and look forward to his continued leadership and support as Executive Committee member of Philips.”

Ms. Xue (American, Chinese) worked for GE Healthcare for more than 25 years, most recently in the role of President and Chief Executive Officer, Global Magnetic Resonance (MR) Imaging. Based on her deep domain knowledge, she developed and executed imaging strategies, delivering consistent profitable growth. With her extensive global experience, particularly in the US, she has served in leadership roles including in Global X-ray, MR, Services and Business Development.

Ms. Fidanci (Turkish) had an extensive career at Philips, with deep expertise serving health systems’ needs, including working directly with both private and public healthcare customers, as well as extensive consumer domain experience. During her 22 years at the company, she took on various roles including Health Systems Leader and Market Leader Middle East & Türkiye, before leaving in September 2021.

Additional information on Philips’ Executive Committee can be found here.
 

For further information, please contact:



Ben Zwirs
Philips External Relations
Tel.: +31 6 1521 3446
E-mail: [email protected]

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments